Who Paid My Doc
Dean Kot
Physician Assistant, Medical Clovis, NM Physician Assistant
NPI 1114431301 CMS profile 11508200
104 W D L Ingram Ave, Clovis, NM 88101
General payments
$94
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Dean Kot of Clovis, NM is reported in the CMS Open Payments database as having received $94 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 23rd percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $94 | 1 |
Beside peers
- Dean Kot
- Physician Assistant, Medical median
- Middle half of Physician Assistant, Medical
- National median
In program year 2025, general payments to Dean Kot were reported at $0. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.
Show as a table
| Year | Dean Kot | Physician Assistant, Medical median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $61 | $19–$193 | $163 |
| 2020 | $0 | $20 | $14–$64 | $114 |
| 2021 | $0 | $156 | $41–$563 | $132 |
| 2022 | $0 | $185 | $55–$649 | $149 |
| 2023 | $94 | $199 | $58–$717 | $160 |
| 2024 | $0 | $206 | $62–$740 | $164 |
| 2025 | $0 | $214 | $62–$755 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 15 drugsPart D claims
455
Drug cost
$2,322
Branded share of claims
27.9%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | Brand | 19 | $410 | |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | Brand | 34 | $246 | |
| Ketorolac Tromethamine | Generic | 15 | $238 | |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | Brand | 28 | $236 | |
| Doxycycline Hyclate | Generic | 31 | $213 | |
| Prednisone | Generic | 97 | $154 | |
| Cephalexin | Generic | 24 | $148 | |
| Fluconazole | Generic | 27 | $136 | |
| Azithromycin | Generic | 41 | $127 | |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | Brand | 35 | $125 |
The 10 drugs with the highest cost, of 15 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 111 billing codesPaid by Medicare
$51,290
Medicare patients
375
Services billed
4,526
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 54% | |
| Chronic kidney disease | 47% | |
| Diabetes | 43% | |
| COPD | 29% | |
| Ischemic heart disease | 28% | |
| Depression | 25% | |
| Heart failure | 23% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 | Office | 19 | 1,725 | $170 |
| Injection, ceftriaxone sodium, per 250 mg J0696 | Office | 81 | 384 | $126 |
| Injection, ketorolac tromethamine, per 15 mg J1885 | Office | 35 | 159 | $80 |
| Injection, dexamethasone sodium phosphate, 1 mg J1100 | Office | 66 | 690 | $55 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 | Office | 13 | 64 | $49 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Physician Assistant, Medical in New Mexico
Brenda Pacheco
Physician Assistant, Medical · Acoma, NM
Paul Tapia
Physician Assistant, Medical · Albuquerque, NM
Niki Ninopoulos
Physician Assistant, Medical · Albuquerque, NM
William Bacon
Physician Assistant, Medical · Santa Fe, NM
Katie Joshi
Physician Assistant, Medical · Albuquerque, NM
Loretta Gonzales
Physician Assistant, Medical · Albuquerque, NM
Related records
Physician Assistant, Medical in New Mexico
Practitioners in the same specialty and state, ranked by reported value.
All Physician Assistant, Medical
Everyone recorded under this specialty, nationwide.
Doctors in New Mexico
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.